Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Infusion Site Pain with Excipients in T1DM
NCT05067270Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of treprostinil and trisodium citrate in type 1 diabetes mellitus (T1D) (5 arms), sponsored by Eli Lilly and Company. Primary endpoint: Visual Analog Scale (VAS) Pain Score at Day 1. Started Oct 2021; status: completed.
02
Drugs
treprostiniltrisodium citrate
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05067270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067270.